Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Alginates × 1 year × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Mucositis 1 Esophagitis 1 Breast Neoplasms 1

Interventions

Fulvestrant 116 Trastuzumab 102 Letrozole 100 Paclitaxel 97 pembrolizumab 71 Capecitabine 66 Anastrozole 63 palbociclib 62 abemaciclib 60 Cyclophosphamide 60 pertuzumab 59 Carboplatin 56 exemestane 53 Tamoxifen 53 ribociclib 52 trastuzumab deruxtecan 51 Radiotherapy 47 Docetaxel 47 Magnetic Resonance Spectroscopy 46 Surveys and Questionnaires 43 Specimen Handling 43 olaparib 37 Blood Specimen Collection 37 sacituzumab govitecan 29 Standard of Care 29 Biopsy 29 Exercise 27 Doxorubicin 27 130-nm albumin-bound paclitaxel 27 eribulin 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡